Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity

Journal Article · · Immunity
 [1];  [2];  [2];  [2];  [2];  [3];  [3];  [2];  [2];  [3];  [3];  [4];  [5];  [6]
  1. The Scripps Research Inst., La Jolla, CA (United States). Dept. of Integrative Structural and Computational Biology; OSTI
  2. The Scripps Research Inst., La Jolla, CA (United States). Dept. of Integrative Structural and Computational Biology
  3. Univ. of Amsterdam (Netherlands). Amsterdam UMC. Dept. of Medical Microbiology
  4. Univ. of Amsterdam (Netherlands). Amsterdam UMC. Dept. of Medical Microbiology; Cornell Univ., Ithaca, NY (United States). Weill Medical College. Dept. of Microbiology and Immunology
  5. The Scripps Research Inst., La Jolla, CA (United States). Dept. of Integrative Structural and Computational Biology; The Scripps Research Inst., La Jolla, CA (United States). IAVI Neutralizing Antibody Center; The Scripps Research Inst., La Jolla, CA (United States). Consortium for HIV/AIDS Vaccine Development (CHAVD)
  6. The Scripps Research Inst., La Jolla, CA (United States). Dept. of Integrative Structural and Computational Biology. IAVI Neutralizing Antibody Center. Consortium for HIV/AIDS Vaccine Development (CHAVD). The Skaggs Institute for Chemical Biology

Most antibodies isolated from individuals with coronavirus disease 2019 (COVID-19) are specific to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, COVA1-16 is a relatively rare antibody that also cross-neutralizes SARS-CoV. Here, we determined a crystal structure of the COVA1-16 antibody fragment (Fab) with the SARS-CoV-2 receptor-binding domain (RBD) and negative-stain electron microscopy reconstructions with the spike glycoprotein trimer to elucidate the structural basis of its cross-reactivity. COVA1-16 binds a highly conserved epitope on the SARS-CoV-2 RBD, mainly through a long complementarity-determining region (CDR) H3, and competes with the angiotensin-converting enzyme 2 (ACE2) receptor because of steric hindrance rather than epitope overlap. COVA1-16 binds to a flexible up conformation of the RBD on the spike and relies on antibody avidity for neutralization. These findings, along with the structural and functional rationale for epitope conservation, provide insights for development of more universal SARS-like coronavirus vaccines and therapies.

Research Organization:
The Scripps Research Inst., La Jolla, CA (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES)
Grant/Contract Number:
AC02-76SF00515
OSTI ID:
1816211
Journal Information:
Immunity, Journal Name: Immunity Journal Issue: 6 Vol. 53; ISSN 1074-7613
Publisher:
Cell PressCopyright Statement
Country of Publication:
United States
Language:
English

References (67)

UCSF Chimera?A visualization system for exploratory research and analysis journal January 2004
Shape Complementarity at Protein/Protein Interfaces journal December 1993
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism journal May 2019
A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface journal May 2019
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein journal April 2020
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies journal May 2020
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells journal July 2020
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies journal August 2020
Molecular Architecture of the SARS-CoV-2 Virus journal October 2020
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections journal June 2020
An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain journal October 2020
Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope journal June 2019
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike journal September 2020
Innovations in structure-based antigen design and immune monitoring for next generation vaccines journal August 2020
Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation journal July 2020
Inference of Macromolecular Assemblies from Crystalline State journal September 2007
Cryo-EM Structure of Full-length HIV-1 Env Bound With the Fab of Antibody PG16 journal February 2020
Automated molecular microscopy: The new Leginon system journal July 2005
Appion: An integrated, database-driven pipeline to facilitate EM image processing journal April 2009
DoG Picker and TiltPicker: Software tools to facilitate particle selection in single particle electron microscopy journal May 2009
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 journal November 2011
Cross-neutralization of influenza A viruses mediated by a single antibody loop journal September 2012
Computational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding site journal June 2017
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence journal November 2015
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses journal February 2020
A pneumonia outbreak associated with a new coronavirus of probable bat origin journal February 2020
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor journal March 2020
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody journal May 2020
Human neutralizing antibodies elicited by SARS-CoV-2 infection journal May 2020
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2 journal May 2020
Convergent antibody responses to SARS-CoV-2 in convalescent individuals journal June 2020
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike journal July 2020
Structures and distributions of SARS-CoV-2 spike proteins on intact virions journal August 2020
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein journal July 2020
Structural insights into the design of novel anti-influenza therapies journal February 2018
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient journal July 2020
Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity journal October 2012
Cell entry mechanisms of SARS-CoV-2 journal May 2020
Altered Dimer Interface Decreases Stability in an Amyloidogenic Protein journal April 2008
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody journal January 2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses journal July 2020
MUSCLE: multiple sequence alignment with high accuracy and high throughput journal March 2004
ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules journal May 2016
WebLogo: A Sequence Logo Generator journal May 2004
Phaser crystallographic software journal July 2007
MolProbity : all-atom structure validation for macromolecular crystallography journal December 2009
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Features and development of Coot journal March 2010
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses journal July 2011
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins journal July 2011
Potent peptidic fusion inhibitors of influenza virus journal September 2017
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation journal February 2020
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 journal March 2020
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period journal April 2020
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV journal April 2020
Site-specific glycan analysis of the SARS-CoV-2 spike journal May 2020
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2 journal May 2020
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability journal June 2020
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2 journal June 2020
Broad neutralization of SARS-related viruses by human monoclonal antibodies journal June 2020
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model journal June 2020
Structural basis of a shared antibody response to SARS-CoV-2 journal July 2020
Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants journal July 2006
Crystal Structure of an Anti-Ang2 CrossFab Demonstrates Complete Structural and Functional Integrity of the Variable Domain journal April 2013
Few and Far Between: How HIV May Be Evading Antibody Avidity journal May 2010
New tools for automated high-resolution cryo-EM structure determination in RELION-3 journal November 2018

Cited By (3)


Similar Records

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Journal Article · Wed Jun 24 00:00:00 EDT 2020 · Cell · OSTI ID:1816377

Structural basis of a shared antibody response to SARS-CoV-2
Journal Article · Mon Jul 13 00:00:00 EDT 2020 · Science · OSTI ID:1816389

Related Subjects